SI0969815T1 - - Google Patents

Info

Publication number
SI0969815T1
SI0969815T1 SI9830767T SI9830767T SI0969815T1 SI 0969815 T1 SI0969815 T1 SI 0969815T1 SI 9830767 T SI9830767 T SI 9830767T SI 9830767 T SI9830767 T SI 9830767T SI 0969815 T1 SI0969815 T1 SI 0969815T1
Authority
SI
Slovenia
Application number
SI9830767T
Inventor
Ngoc-Anh Thi Nguyen
Warren M Casey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SI0969815T1 publication Critical patent/SI0969815T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
SI9830767T 1997-03-24 1998-03-20 SI0969815T1 (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation
PCT/EP1998/001626 WO1998042321A2 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine
EP98919120A EP0969815B1 (en) 1997-03-24 1998-03-20 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SI0969815T1 true SI0969815T1 (xx) 2005-08-31

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830767T SI0969815T1 (xx) 1997-03-24 1998-03-20

Country Status (40)

Country Link
US (1) US6004968A (xx)
EP (1) EP0969815B1 (xx)
JP (1) JP3264937B2 (xx)
KR (1) KR100484695B1 (xx)
CN (1) CN1191061C (xx)
AP (1) AP1141A (xx)
AR (1) AR011697A1 (xx)
AT (1) ATE295150T1 (xx)
AU (1) AU728461B2 (xx)
BG (1) BG64690B1 (xx)
BR (1) BR9808060B1 (xx)
CA (1) CA2286126C (xx)
CO (1) CO4980849A1 (xx)
CY (1) CY2569B1 (xx)
CZ (1) CZ298008B6 (xx)
DE (1) DE69830154T2 (xx)
EA (1) EA001990B1 (xx)
EE (1) EE03996B1 (xx)
ES (1) ES2239802T3 (xx)
HK (1) HK1022853A1 (xx)
HN (1) HN1998000045A (xx)
HR (1) HRP980154B1 (xx)
HU (1) HU225600B1 (xx)
ID (1) ID29294A (xx)
IL (1) IL131917A0 (xx)
IS (1) IS2515B (xx)
MY (1) MY116242A (xx)
NO (1) NO326719B1 (xx)
NZ (1) NZ337798A (xx)
PA (1) PA8449301A1 (xx)
PE (1) PE61699A1 (xx)
PL (1) PL190505B1 (xx)
PT (1) PT969815E (xx)
RS (1) RS49772B (xx)
SI (1) SI0969815T1 (xx)
SK (1) SK283417B6 (xx)
SV (1) SV1998000040A (xx)
TW (1) TW536403B (xx)
UY (1) UY24930A1 (xx)
WO (1) WO1998042321A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9709939A (pt) 1996-06-25 1999-08-10 Glaxo Group Ltd Combinação formulação farmacêutica processo de tratamento de uma infecção por hiv em um animal infectado usos de éster tetraidro-3-furanila do ácido 3s[3r*(1r*,2s*)]-[-3-[[4-amino-fenil)sulfonil](2-metilprop ril)-amino]-2-hidroxi-1-fenilmetil)propil]-carbâmico de zidovudina e de (2r,cis)-4-amino-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona e pacote para paciente
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
WO2004075913A1 (ja) 2003-02-28 2004-09-10 Chugai Seiyaku Kabushiki Kaisha タンパク質含有安定化製剤
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华(广州)医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
US20110117193A1 (en) * 2008-01-17 2011-05-19 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
SK279262B6 (sk) * 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
EA199900757A1 (ru) 2000-08-28
NO994619L (no) 1999-11-23
IL131917A0 (en) 2001-03-19
NZ337798A (en) 2001-03-30
PL190505B1 (pl) 2005-12-30
JP2001501974A (ja) 2001-02-13
PL336038A1 (en) 2000-06-05
CA2286126A1 (en) 1998-10-01
UY24930A1 (es) 2000-10-31
PA8449301A1 (es) 2000-05-24
DE69830154T2 (de) 2005-10-13
MY116242A (en) 2003-12-31
CN1191061C (zh) 2005-03-02
HU225600B1 (en) 2007-05-02
CA2286126C (en) 2003-08-12
AP9901657A0 (en) 1999-09-30
WO1998042321A3 (en) 1999-01-07
BR9808060B1 (pt) 2009-05-05
EP0969815B1 (en) 2005-05-11
EE9900440A (et) 2000-04-17
BG103818A (en) 2000-06-30
JP3264937B2 (ja) 2002-03-11
US6004968A (en) 1999-12-21
KR100484695B1 (ko) 2005-04-22
IS5184A (is) 1999-09-17
TW536403B (en) 2003-06-11
PE61699A1 (es) 1999-07-08
DE69830154D1 (de) 2005-06-16
PT969815E (pt) 2005-07-29
AR011697A1 (es) 2000-08-30
HN1998000045A (es) 1999-03-19
IS2515B (is) 2009-06-15
CN1255849A (zh) 2000-06-07
HRP980154A2 (en) 1998-12-31
IL131917A (en) 2001-01-11
SK283417B6 (sk) 2003-07-01
EE03996B1 (et) 2003-04-15
CZ298008B6 (cs) 2007-05-23
ATE295150T1 (de) 2005-05-15
BR9808060A (pt) 2000-03-08
RS49772B (sr) 2008-06-05
CO4980849A1 (es) 2000-11-27
HK1022853A1 (en) 2000-08-25
CZ340399A3 (cs) 2000-04-12
NO994619D0 (no) 1999-09-23
KR20010005624A (ko) 2001-01-15
AU7208498A (en) 1998-10-20
BG64690B1 (bg) 2005-12-30
HUP0002982A3 (en) 2001-12-28
HUP0002982A2 (hu) 2001-01-29
SK129999A3 (en) 2000-07-11
YU47799A (sh) 2002-06-19
WO1998042321A2 (en) 1998-10-01
AP1141A (en) 2003-01-29
NO326719B1 (no) 2009-02-02
ES2239802T3 (es) 2005-10-01
CY2569B1 (en) 2008-07-02
EP0969815A2 (en) 2000-01-12
EA001990B1 (ru) 2001-10-22
ID29294A (id) 2001-08-16
AU728461B2 (en) 2001-01-11
HRP980154B1 (en) 2002-06-30
SV1998000040A (es) 1999-03-16

Similar Documents

Publication Publication Date Title
BE2018C032I2 (xx)
IN232869B (xx)
IN192208B (xx)
JP2001510058A5 (xx)
CH0944937H2 (xx)
ITMI971329A0 (xx)
ITVE970012A0 (xx)
ITMI971358A0 (xx)
IN187315B (xx)
IN186426B (xx)
ITMI970378V0 (xx)
ITLI970004V0 (xx)
ITAN970027V0 (xx)
BR9700653A (xx)
ITMI971095A0 (xx)
IN192796B (xx)
BR9701757A (xx)
ITMI971122A0 (xx)
IN191031B (xx)
IN190642B (xx)
ECSDI970388S (xx)
ITMI971193A0 (xx)
IN188655B (xx)
IN188318B (xx)
ECSDI970403S (xx)